Kineto-DP Capsule is a combination pharmaceutical formulation containing Diclofenac 50 mg and Serratiopeptidase 15 mg, designed for the management of pain and inflammation associated with musculoskeletal disorders, postoperative conditions, and traumatic injuries. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. Serratiopeptidase, a proteolytic enzyme, complements this action by facilitating the breakdown of inflammatory mediators and promoting the resolution of edema and tissue repair. The synergistic effect of these agents provides effective relief from acute and chronic inflammatory conditions, enhancing patient comfort and mobility. Kineto-DP Capsule is indicated for conditions such as arthritis, tendonitis, bursitis, and postoperative swelling. It should be administered under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with cardiovascular, hepatic, or renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions. Regular monitoring is recommended during prolonged therapy to mitigate potential risks. Kineto-DP Capsule offers a balanced approach to inflammation management by combining analgesic and proteolytic actions in a single dosage form.